Holen Sie sich die Stockscreener-App
31.06
4.47%
1.33
Handel nachbörslich:
31.49
0.43
+1.38%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$29.73
Offen:
$29.13
24-Stunden-Volumen:
705.57K
Relative Volume:
0.64
Marktkapitalisierung:
$1.78B
Einnahmen:
$2.19B
Nettoeinkommen (Verlust:
$-829.17M
KGV:
-2.1796
EPS:
-14.25
Netto-Cashflow:
$-3.95M
1W Leistung:
+2.41%
1M Leistung:
-2.08%
6M Leistung:
-3.87%
1J Leistung:
-22.52%
1-Tages-Spanne:
$29.00
$31.61
1-Wochen-Bereich:
$29.00
$32.11
52-Wochen-Spanne:
$25.46
$49.83
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Vergleichen Sie ENOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
31.06 | 1.70B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Is Enovis Corporation stock a defensive play in 2025July 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
What to expect from Enovis Corporation in the next 30 days2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Why Investors Shouldn't Be Surprised By Enovis Corporation's (NYSE:ENOV) Low P/S - 富途牛牛
Is Enovis Corporation (C520) stock bottoming after sell off2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
How Enovis Corporation stock compares to growth peersJobs Report & Accurate Technical Buy Alerts - newser.com
Enovis Sells Dr. Comfort Business to Promus Equity Partners for Up to $60 Million - MyChesCo
Key resistance and support levels for Enovis CorporationJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How hedge fund analytics apply to Enovis Corporation stock2025 Major Catalysts & Breakout Confirmation Trade Signals - newser.com
Lawson Kroeker Investment Management Inc. NE Buys 13,566 Shares of Enovis Corporation $ENOV - MarketBeat
A Fresh Look at Enovis (ENOV) Valuation After Dr. Comfort Segment Sale and Strategic Refocus - Yahoo Finance
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know - Yahoo Finance
What downside risks could hit Enovis Corporation (C520) stockEarnings Miss & High Conviction Investment Ideas - newser.com
Applying Elliott Wave Theory to Enovis CorporationJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Enovis (NYSE:ENOV) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Enovis (ENOV) Stock Trades Up, Here Is Why - Yahoo Finance
Enovis Sells Dr. Comfort Footcare Solutions Business To Promus Equity Partner For $60M - citybiz
Enovis (ENOV) Divests Dr. Comfort Shoe Business for Up to $60 Mi - GuruFocus
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million - The Manila Times
Enovis Corporation Sells Dr. Comfort Diabetic Shoe Business to Promus Equity Partners for Up to $60 Million - Quiver Quantitative
Up to $60M proceeds — Enovis completes sale of Dr. Comfort to Promus Equity Partners Oct. 8, 2025 - Stock Titan
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $44 - 富途牛牛
What analysts say about Enovis Corporation C520 stockStock Price Divergence & Low Risk Wealth Building - earlytimes.in
DAVENPORT & Co LLC Sells 228,850 Shares of Enovis Corporation $ENOV - MarketBeat
Can Enovis Corporation rally from current levelsQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Can Enovis Corporation (C520) stock sustain breakout momentumWeekly Market Summary & Safe Entry Zone Identification - newser.com
Long term hold vs stop loss in Enovis Corporation2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Enovis (ENOV): Exploring the Stock’s Undervalued Status After Recent 5% Upswing - simplywall.st
Shareholders in Enovis (NYSE:ENOV) Have Lost 17%, as Stock Drops 14% This Past Week - 富途牛牛
Lecap Asset Management Ltd. Buys New Stake in Enovis Corporation $ENOV - MarketBeat
Public Employees Retirement System of Ohio Decreases Stock Position in Enovis Corporation $ENOV - MarketBeat
Volatility clustering patterns for Enovis CorporationPortfolio Return Report & AI Powered Market Entry Ideas - newser.com
Smart tools for monitoring Enovis Corporation’s price action2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
What is the fair value of Enovis Corporation stock nowDollar Strength & Real-Time Volume Surge Alerts - newser.com
Enovis CEO Matt Trerotola Announces Retirement, Leadership Transition Underway - MSN
Is Enovis Corporation C520 a good long term investmentResistance Breakout Alerts & Minimal Capital Growth - Early Times
Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago - 富途牛牛
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):